Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000221267 | SCV000202455 | likely benign | not specified | 2017-03-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000488218 | SCV000235824 | benign | not provided | 2021-03-02 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000221267 | SCV000270122 | likely benign | not specified | 2016-02-18 | criteria provided, single submitter | clinical testing | p.Thr418Ser in exon 11 of DMD: This variant is not expected to have clinical sig nificance because it was seen in 20/47913 European chromosomes, including 5 hem izygotes, by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; dbSNP rs201341211) and due to a lack of conservation across species, includ ing mammals. Of note, >5 mammals (Ferret, Panda, Pacific Walrus, Weddell seal, M anatee, Armadillo, Platypus) have serine (Ser) at this position despite high nea rby amino acid conservation. In addition, computational prediction tools do not suggest a high likelihood of impact to the protein. |
Labcorp Genetics |
RCV001088321 | SCV000560797 | benign | Duchenne muscular dystrophy | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000488218 | SCV000575628 | likely benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | DMD: BP4, BS1 |
Ambry Genetics | RCV002408680 | SCV002680988 | benign | Cardiovascular phenotype | 2018-02-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000488218 | SCV004564875 | likely benign | not provided | 2023-06-15 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000488218 | SCV001798373 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000488218 | SCV001972437 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001826820 | SCV002090391 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2019-06-24 | no assertion criteria provided | clinical testing |